Why Batch Testing Matters for Research Peptides
Not all research peptide suppliers test every batch. Here is why third-party batch-level testing is non-negotiable for credible research, and what you should expect in a quality Certificate of Analysis (COA).
The problem with untested peptides
Synthetic peptide manufacturing is a multi-step chemical process involving solid-phase peptide synthesis (SPPS), cleavage, purification, and lyophilization. At each stage, impurities can accumulate: truncated sequences, deletion products, oxidized residues, racemized amino acids, or residual protecting groups from synthesis.
A peptide that visually appears as a white powder may range from 70% to 99%+ purity depending on synthesis quality and post-synthesis purification. Without independent analytical testing, there is no reliable way to know what you actually have — and impure compounds can compromise the validity of research results.
What HPLC purity testing tells you
High-Performance Liquid Chromatography (HPLC) separates a peptide sample by its interaction with a stationary phase column under controlled solvent conditions. The resulting chromatogram shows peaks for each detected compound — the target peptide peak versus all impurity peaks. Purity is reported as the percentage of the total peak area attributable to the target compound.
Beyond purity, HPLC also confirms compound identity through retention time analysis. Each peptide has a characteristic retention time (the time it takes to elute from the column under specific solvent and temperature conditions). When a sample is run against a known reference standard of the target peptide, the test compound's retention time must match within acceptable tolerance — typically ±2–5%. This matching retention time, combined with UV absorbance at characteristic wavelengths, provides strong confirmatory evidence that the detected peak is indeed the target compound and not a misidentified or contaminated substance.
- ≥98% HPLC: research grade — suitable for most preclinical and in vitro applications
- 95–97% HPLC: acceptable for many applications but may affect assay reproducibility
- Below 95%: generally not suitable for reliable research applications
- HPLC confirms identity via retention time matching and UV absorbance profiles against reference standards
Third-party vs in-house testing
In-house testing by the supplier is an inherent conflict of interest. An independent, accredited third-party laboratory has no financial stake in the outcome and applies standardized methods under quality management systems (ISO/IEC 17025 or equivalent).
At ACCUTIDE Research Supply, all batch testing is performed by independent third-party laboratories. COA documentation is available for every product we ship — see our COA request page.
What testing does NOT tell you
A COA confirms purity and identity of the chemical compound. It does not:
- Predict biological activity in any specific assay system
- Confirm safety or efficacy in any application
- Constitute medical or clinical evidence
- Validate the compound for human use
Related guides: How to read a COA · What is RUO? · Browse our research peptide catalog